Figure 3.

Characteristic first derivative MS-HRMA plots for the semi-quantitative estimation of% methylation for CST6 promoter methylation by MS-HRMA in six tumor FFPE samples:T5:10%, T9: 50%, T13: 1%, T33: 5%, T44: 20% and T52: 20%. Blue: 0%, Red: 50%.

Dimitrakopoulos et al. BMC Cancer 2012 12:486   doi:10.1186/1471-2407-12-486
Download authors' original image